--- a
+++ b/clusters/9knumclustersv2/clust_1405.txt
@@ -0,0 +1,185 @@
+No current peripheral neuropathy > grade  at time of randomization
+Grade  or greater peripheral neuropathy
+Peripheral neuropathy Grade ? 
+Peripheral neuropathy of any etiology that exceeds grade 
+=< grade  peripheral neuropathy
+RE-REGISTRATION ELIGIBILITY CRITERIA (STEP ): =< grade  peripheral neuropathy
+Peripheral neuropathy >= 
+Grade >=  peripheral neuropathy
+Peripheral neuropathy ? Grade .
+Grade >=  peripheral neuropathy at the present time
+Peripheral neuropathy of Grade  within  weeks prior to the first study therapy
+Peripheral neuropathy ?grade .
+Grade  or greater peripheral neuropathy
+Peripheral neuropathy >= grade  at screening
+Peripheral neuropathy > Grade  despite supportive therapy.
+Peripheral neuropathy of severity greater than grade 
+Peripheral neuropathy greater than or equal to Grade 
+Participants with >= grade  peripheral neuropathy
+Baseline peripheral neuropathy of severity > grade 
+Presence of >= grade  peripheral neuropathy
+Peripheral neuropathy >= grade 
+Presence of peripheral neuropathy > grade 
+Peripheral neuropathy =< grade  at the time of registration
+Presence of > grade  peripheral neuropathy
+Peripheral neuropathy >Grade 
+Grade >=  peripheral neuropathy
+Peripheral neuropathy > grade 
+Clinically significant (>= grade ) peripheral neuropathy at the time of study entry
+Peripheral neuropathy grade > 
+Peripheral neuropathy > grade , except for grade  without limitations on instrumental daily life activities;
+Has greater than Grade  peripheral sensory neuropathy or > Grade  peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies.
+Active >= grade  peripheral neuropathy
+Peripheral neuropathy > grade 
+Peripheral neuropathy grade  or less.
+No peripheral neuropathy
+Baseline grade II peripheral neuropathy
+Current peripheral neuropathy >= grade 
+Peripheral neuropathy >= grade  at screening
+Peripheral neuropathy grade  or greater
+Participants with baseline peripheral neuropathy greater than grade 
+Peripheral neuropathy >= grade 
+Baseline grade II peripheral neuropathy
+ENTRECTINIB EXCLUSION CRITERIA: Peripheral neuropathy >= grade 
+Grade >=  peripheral neuropathy at baseline (within  days prior to cycle  day )
+No peripheral edema >= grade  at baseline
+No peripheral neuropathy >= grade  at baseline
+Peripheral neuropathy, if present, should be =< grade 
+Peripheral neuropathy > grade  if due to brentuximab vedotin or any peripheral neuropathy > grade 
+Peripheral neuropathy grade -
+Peripheral neuropathy > grade 
+Peripheral neuropathy >= grade 
+Has > Grade  peripheral sensory neuropathy or > Grade  peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies
+Has history of Grade  or greater peripheral neuropathy during the  months prior to enrollment.
+Patient with peripheral neuropathy Grade >
+Grade >=  peripheral neuropathy
+Grade >=  peripheral neuropathy
+>= grade  peripheral neuropathy
+Peripheral neuropathy >= grade  despite supportive therapy
+Central nervous system (CNS) toxicity including peripheral neuropathy =< grade 
+Peripheral neuropathy of severity greater than grade 
+Greater than grade  peripheral neuropathy at baseline
+Peripheral neuropathy >= grade  at baseline OR peripheral neuropathy >= grade I with neuropathic pain
+Grade >  peripheral neuropathy at baseline (within  days prior to cycle  day )
+Subject has >= grade  peripheral neuropathy
+Peripheral neuropathy >= grade 
+Patients with > grade  peripheral sensory neuropathy or > grade  peripheral motor neuropathy graded according to the Modified (Balis) Pediatric Scale of Peripheral Neuropathies are not eligible
+Peripheral neuropathy >= grade 
+Peripheral neuropathy >= grade 
+Peripheral neuropathy =< grade 
+>= grade  peripheral neuropathy
+>= grade  peripheral neuropathy within  days before beginning maintenance therapy
+Peripheral neuropathy grade  or greater
+Has peripheral neuropathy ? Grade .
+Peripheral neuropathy =< grade 
+Has peripheral neuropathy ? Grade 
+Subjects with baseline peripheral neuropathy that exceeds grade 
+Significant symptoms (grade >= ) peripheral neuropathy
+Peripheral neuropathy ? Grade  or ? Grade  with pain within  weeks prior to first dose
+Peripheral neuropathy ? Grade 
+Peripheral neuropathy ? Grade .
+Has peripheral neuropathy ? Grade 
+Current Grade > peripheral neuropathy
+Grade ?  peripheral neuropathy
+Equal to or greater than grade  ataxia, cranial or peripheral neuropathy
+Peripheral neuropathy < grade 
+Grade >=  peripheral neuropathy
+Current Grade > peripheral neuropathy from any cause
+Peripheral neuropathy exclusions
+? Grade  peripheral neuropathy
+Baseline peripheral neuropathy/paresthesia grade >= 
+Patient has >= grade  peripheral neuropathy
+Patient has >= grade  peripheral neuropathy
+Serious peripheral neuropathy.
+Peripheral neuropathy- grade  or greater
+Peripheral neuropathy ? Grade .
+Peripheral neuropathy grade  or greater
+Participants who have more than grade  peripheral neuropathy
+Peripheral neuropathy >= grade 
+Peripheral neuropathy < grade 
+Clinically significant peripheral neuropathy
+Has baseline peripheral neuropathy/paresthesia grade ? .
+Evidence of peripheral neuropathy of Grade >.
+Subject has peripheral neuropathy ? grade .
+Peripheral neuropathy >= grade 
+Equal to or greater than grade  ataxia, cranial or peripheral neuropathy
+Grade  or above peripheral neuropathy
+Peripheral neuropathy: must be =< grade 
+Grade >  peripheral neuropathy at baseline
+Grade >=  peripheral neuropathy within  days prior to cycle  day 
+Peripheral neuropathy =< grade  at the time of registration
+The patient has peripheral neuropathy >= grade 
+Grade >=  peripheral neuropathy within  days prior to initiation of therapy
+Subject has peripheral neuropathy >= grade .
+Peripheral neuropathy ? Grade  despite supportive therapy
+Has baseline peripheral neuropathy/paresthesia
+Peripheral neuropathy > Grade .
+Patient has >= grade  peripheral neuropathy
+Peripheral neuropathy greater than Grade 
+Peripheral neuropathy >= grade  at baseline OR peripheral neuropathy >= grade I with neuropathic pain
+No peripheral neuropathy greater than grade , due to any cause
+Peripheral neuropathy: must be =< grade 
+Grade  or more peripheral neuropathy
+Peripheral neuropathy ? Grade 
+Peripheral neuropathy >= grade 
+No ? grade  peripheral neuropathy.
+Peripheral neuropathy =< grade 
+Peripheral neuropathy >= grade (Gr) II
+Peripheral neuropathy =< grade 
+Grade  peripheral neuropathy
+Patient has >= grade  peripheral neuropathy
+Peripheral neuropathy
+Peripheral neuropathy > grade 
+> grade  peripheral neuropathy at baseline
+Peripheral neuropathy of grade  or greater
+Presence of ? Grade  peripheral neuropathy
+Peripheral neuropathy ? Grade .
+Presence of clinically significant non-hematological toxicity of prior chemotherapy that has not resolved to ? Grade  as determined by CTCAE v ., with the exception of alopecia and peripheral neuropathy. Note: Peripheral neuropathy > Grade  plus pain, or Grade  or Grade  are excluded.
+Presence of > Grade  peripheral neuropathy
+Peripheral neuropathy ? Grade 
+Peripheral edema > grade 
+Baseline peripheral neuropathy ? grade .
+Peripheral neuropathy ? grade .
+Grade >=  peripheral neuropathy
+Peripheral neuropathy greater than grade 
+Evidence of peripheral neuropathy of Grade > 
+Subjects with > grade  peripheral neuropathy
+Peripheral neuropathy Grade >/=
+Presence of peripheral neuropathy
+Subjects with Grade > peripheral neuropathy
+Peripheral neuropathy at study entry
+Ongoing Grade  or Grade  peripheral neuropathy, or Grade  peripheral neuropathy with pain despite appropriate interventions, within  days prior to first dose of study treatment.
+No grade >=  peripheral neuropathy
+Patient has >= grade  peripheral neuropathy
+Grade >= peripheral neuropathy
+Baseline peripheral edema >= grade 
+Peripheral neuropathy ?Grade .
+>= grade  peripheral neuropathy
+Peripheral neuropathy
+Current Grade > peripheral neuropathy
+History of peripheral neuropathy; (note: this does not apply to Cohort )
+Grade >= peripheral neuropathy
+Grade ? peripheral neuropathy at baseline (within  days prior to cycle  day ).
+Grade  or greater peripheral neuropathy
+Peripheral neuropathy >= grade 
+Peripheral neuropathy that is greater or equal to Grade 
+Has peripheral neuropathy that is greater or equal to Grade 
+Patient has > Grade  painful neuropathy or peripheral neuropathy
+Peripheral neuropathy ? Grade 
+The participant has any Grade  (or greater) peripheral neuropathy.
+No grade  or greater peripheral neuropathy.
+History of peripheral neuropathy of ?grade 
+Peripheral neuropathy of > grade  severity.
+Peripheral neuropathy with grade =< 
+Clinically significant (>= grade ) peripheral neuropathy at the time of study entry
+Peripheral neuropathy >= grade 
+Grade >=  peripheral neuropathy
+Any peripheral neuropathy >= grade 
+Grade III or IV upper extremity peripheral neuropathy
+History of peripheral neuropathy prior to receiving neurotoxic chemotherapy
+Pain or symptoms of peripheral neuropathy of >  month's duration attributed to chemotherapy-induced peripheral neuropathy
+Peripheral neuropathy greater than or equal to grade .
+No >= grade  peripheral neuropathy
+Peripheral neuropathy ? grade 
+Peripheral neuropathy greater than grade 
+Peripheral neuropathy greater than grade